Worcester
Your Local News for Worcester, Massachusetts
Subscribe
Subscribe
Thursday, jun 25
60°
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Tags
Jobs
Shop
Support Us
Worcester
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Lifestyle
Politics
Sports
Traffic
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2026 Cantata Media
60°
Thursday, jun 25
Lifestyle
Covid-
19: CDC Reveals Percentage Of Americans Who Haven't Gotten Second Dose
A significant number of Americans who received their first COVID-19 shot have missed their second dose, causing concern as the number of new cases from the Delta variant grows, according to the Centers for Disease Control and Prevention (CDC). The CDC said this week that more than 10 percent of Americans have received just one dose and opted to skip the second vaccine, which could prove problematic as the more transmissible Delta COVID-19 variant continues to rapidly spread and become more dominant. According to the CDC, just 88 percent of those who received one dose of the Moderna or Pfize…
News
Covid-
19: New
Us-m
ade Vaccine Has 90 Percent Efficiency Rate, Can Be Stored In Refrigerators
An American biotech company announced that it has concluded the latest phase of clinical trials for its COVID-19 vaccine, which has proven to be highly effective. Novavax announced on Monday, June 14 that its vaccine has an overall efficacy rate of 90.4 percent in a Phase 3 trial that took place across the United States and Mexico. The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute. Additional analysis of the trial is ongoing, according to the company, and will be submitted to peer-reviewed journals for publication. The company said that the vacc…
News
Covid-
19: Pfizer Begins Vaccine Study On Younger Children
Pfizer is moving forward with new clinical tests on thousands of children under the age of 12 as they look to expand the authorization of its COVID-19 vaccine. The company announced on Tuesday, June 8 that it will enroll up to 4,500 children between the ages of 6 months and 12 years old in the United States, Finland, Poland, and Spain with the intention of getting emergency use authorization before school begins in the fall. Currently, the Pfizer vaccine has only been authorized for use in children 12 and older. According to Pfizer, it has selected a dose of 10 micrograms in children betw…
News
Covid-
19: CDC Releases Brand-New Data On Hospitalized, Fatal Vaccine Breakthrough Cases
The Centers for Disease Control & Prevention (CDC) has released brand-new data on the number of people who have been hospitalized or died despite being fully vaccinated for COVID-19. To be fully vaccinated, two weeks or more must have passed since they received the second dose of the Pfizer or Moderna vaccine or the single-dose Johnson & Johnson vaccine. As of Monday, May 17, more than 123 million people in the United States had been fully vaccinated. During that time, the CDC said it received a total of 1,949 reports from 47 states and territories of vaccine brea…
News
Covid-
19: New Time Frame Provided For When Vaccine Booster Shots May Be Necessary
Executives and experts at the center of COVID-19 pandemic response are now providing a more specific possible time frame for when Americans who were first to receive a vaccine dose may need to take a booster shot. Pfizer CEO Albert Bourla, speaking during an Axios event, said that the data he has reviewed supports the notion "that likely there will be a need for a booster somewhere between eight and 12 months" after the initial vaccination regime. That means those who were among the first to get a vaccine shot in mid to late December 2020 or early January 2021 would likely need a booster sh…
Business
Covid-
19: These Retailers Are Allowing Maskless Shopping For Fully Vaccinated
With the Centers for Disease Control and Prevention (CDC) and most states loosening up mask-wearing restrictions, many retailers are following suit and are enacting new policies for customers and employees. The CDC said last week that fully vaccinated people do not need to wear a mask or stay 6 feet apart from others in most cases, whether indoors or outdoors. People are considered fully vaccinated two weeks after they receive the second dose of the Pfizer or Moderna vaccines or the single dose of Johnson & Johnson. The following mandates are in place at thes…
Sports
Covid-
19: Details Emerge On Vaccine Brand Taken By Star Shortstop, Seven Other Infected Yankees
Despite being fully vaccinated for COVID-19, eight members of the New York Yankees still tested positive for the virus after receiving the one-dose Johnson & Johnson shot. The eight are: starting shortstop Gleyber Torres, third base coach Phil Nevin, first base coach Reggie Willits, pitching coach Matt Blake, and four support staffers. Related story - COVID-19: Fully Vaccinated TV Host, Star Shortstop, Seven Other NY Yankees Test Positive According to the initial clinical trial results, the single-dose Johnson & Johnson vaccine has proven to be 72 percent effective against COVID-1…
News
Covid-
19: CDC Issues Brand-New Guidance On Mask-Wearing Indoors
The Centers for Disease Control and Prevention (CDC) is easing indoor mask-wearing guidance for Americans who are fully vaccinated for COVID-19. On Thursday afternoon, May 13, CDC Director Dr. Rochelle Walensky announced the new guidance at a White House briefing, saying that anyone who has received both shots of the Pfizer or Moderna vaccine, or the one-dose Johnson & Johnson shot can safely stop wearing masks indoors, except under some circumstances. The new guidance calls for continued mask-wearing in more crowded indoor spaces such as on mass transportation, hospitals, prisons, or …
News
Covid-
19: CDC Advisory Panel Endorses Use Of Pfizer Vaccine In Children 12 And Up
A panel of experts advising the Centers for Disease Control and Prevention (CDC) voted to move forward with the approval process for the use of the Pfizer COVID-19 vaccine among children between the ages of 12 and 15. By a 14-0 vote on Wednesday afternoon, May 12, the CDC panel recommended the use of the Pfizer vaccine in children 12 and up, with the decision now moving forward to CDC Director Dr. Rochelle Walensky for final approval. Once approved by Walensky, which is expected to happen quickly, it will be at states’ discretion about whether or not to move forward vaccinating children. …
Business
Covid-
19: Moderna Will Double Size Of Vaccine Manufacturing Space
With the goal of producing billions of COVID-19 vaccine doses by the end of 2022, Moderna announced that it will be expanding its production facility, located in New England. The biotechnology company, which is currently one of three companies that have been granted emergency use authorization to produce COVID-19 vaccines in the United States (along with Pfizer and Johnson & Johnson), announced that it will be doubling the size of the Moderna Technology Center in Norwood, Massachusetts. According to the company, the expansion includes an increase of the company’s production and lab spac…
News
Covid-
19: Infection Surge In World's Most Vaccinated Nation Sparks Search For Answers
One of the world's most vaccinated countries has seen a new rise in COVID-19 cases, forcing researchers to question whether this is a trend or anomaly. Seychelles, a small island country in East Africa that has fully vaccinated the majority of its population, has taken steps to close schools and canceled sports activities for the next two weeks due to a recent surge of the virus. According to Bloomberg, precautionary measures being taken in Seychelles include a ban on the intermingling of households and the early closure of bars, despite the fact that the country has vaccinated more than 6…
News
Covid-
19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants
Both Pfizer and Moderna - two of the three COVID-19 vaccines approved for distribution in the US - have seen promising results in combating variants of the virus in recent studies. This week, both pharmaceutical companies released results of clinical trials that show the vaccines are effective in combating COVID-19 variants, including the prominent strains from South Africa and Brazil. Moderna has been testing a 50-microgram dose of its vaccine in previously vaccinated people, which found the booster dose increased neutralizing antibody responses against the original virus as well as the va…
Next Page
Archive
60°
